Results 41 to 50 of about 73,485 (336)

Expression of salivary biomarkers in patients with oral mucositis: evaluation by SELDI-TOF/MS [PDF]

open access: yes, 2016
OBJECTIVE: This study aims to evaluate changes in proteomic salivary profile of patients with oral mucositis after adjuvant cancer treatments. MATERIALS AND METHODS: Samples were collected from patients after adjuvant cancer therapies, and were analyzed ...
Ardito, F.   +8 more
core   +2 more sources

The therapeutic effect of PLAG against oral mucositis in hamster and mouse model

open access: yesFrontiers in Oncology, 2016
Chemotherapy-induced mucositis can limit the effectiveness of cancer therapy and increase the risk of infections. However, no specific therapy for protection against mucositis is currently available.
Ha-Reum Lee   +9 more
doaj   +1 more source

Nutritional and Post-Transplantation Outcomes of Enteral versus Parenteral Nutrition in Pediatric Hematopoietic Stem Cell Transplantation: A Systematic Review of Randomized and Nonrandomized Studies [PDF]

open access: yes, 2019
Hematopoietic stem cell transplantation (HSCT) involves the administration of chemotherapy followed by the infusion of donor stem cells. After treatment, children can consequently experience nausea, vomiting, diarrhea, anorexia, and mucositis, which ...
Evans, J. C.   +2 more
core   +1 more source

Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. [PDF]

open access: yes, 2014
BackgroundSince PI3K/AKT/mTOR pathway activation diminishes the effects of hormone therapy, combining aromatase inhibitors (anatrozole) with mTOR inhibitors (everolimus) was investigated.Patients and methodsWe evaluated anastrozole and everolimus in 55 ...
Atkins, Johnique T   +13 more
core   +7 more sources

Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. [PDF]

open access: yesPLoS ONE, 2014
Objective was to determine whether prophylactic low level laser therapy (LLLT) reduces the risk of severe mucositis as compared to placebo or no therapy.MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched until February 2014
Sapna Oberoi   +4 more
doaj   +1 more source

Examination of nursing theses on oral mucositis in children with cancer in Turkey

open access: yesProblemy Pielęgniarstwa
Oral mucositis is common in children with cancer. Nurses are effective in the management of oral mucositis. For this reason, the study was conducted to examine nursing theses regarding oral mucositis in children with cancer in Turkey.
Şule Çalışır Kundakçı   +2 more
doaj   +1 more source

Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail

open access: yesContemporary Clinical Dentistry, 2011
Background and Objectives: Oral mucositis is a common and debilitating complication of radiotherapy, which is associated with significant morbidity.
G Roopashri, K Jayanthi, R Guruprasad
doaj   +1 more source

Correlation of oral mucositis with timing of radiation in head and neck cancer - A prospective randomized study on chronoradiotherapy

open access: yesJournal of Radiation and Cancer Research, 2021
Context: Study to reduce oral mucositis using chronoradiotherapy. Aims: This study aims to assess and compare oral mucositis and weight loss between two groups of patients on radiation-morning and evening group.
Lithika M Lavanya, T R Arulponni
doaj   +1 more source

Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations

open access: yesAdvanced Functional Materials, EarlyView.
Intraoral drug delivery offers a promising route for systemic and localized therapies, yet challenges such as enzymatic degradation, limited permeability, and microbial interactions hinder efficacy. This figure highlights innovative strategies—mucoadhesive materials, enzyme inhibitors, and permeation enhancers—to overcome these barriers.
Soheil Haddadzadegan   +4 more
wiley   +1 more source

Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration [PDF]

open access: yes, 2020
Background Immune checkpoint inhibitors such as nivolumab and targeted BRAF inhibitors have dramatically altered the treatment outcomes of metastatic melanoma over the past few years. Skin toxicity is the most common adverse event (AE) related to the
Maestro, Alessandra   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy